Betahistine
Is It Right for You?
A complete guide to Betahistine — what it treats, how it works, dosages, side effects, and when a clinician may prescribe it following an online consultation.
What Is Betahistine?
Betahistine is a histamine analogue used in the treatment of Ménière's disease — a disorder of the inner ear characterised by episodic vertigo, hearing loss, tinnitus, and a sensation of fullness or pressure in the ear. It is one of the most widely prescribed treatments for Ménière's disease in Europe and is also used in the management of other vestibular disorders associated with vertigo and dizziness.
Betahistine has a long history of clinical use dating back to the 1960s and is valued for its ability to reduce the frequency and severity of vertigo attacks in Ménière's disease over the long term, rather than merely suppressing acute symptoms. Unlike vestibular sedatives used for acute vertigo (such as prochlorperazine), betahistine is taken regularly to modify the underlying pathophysiology of endolymphatic hydrops — the accumulation of fluid in the inner ear that is thought to underlie Ménière's disease.
Available in 8 mg and 16 mg tablets, betahistine is suitable for adults. It requires consistent, long-term administration — typically for months to years — for maximum benefit, and is not an acute rescue medication.
Betahistine is a prescription-only medication in the UK. A licensed clinician must assess your symptoms and medical history before it can be prescribed — which can now be done quickly and conveniently through a telehealth consultation.
What Conditions Is Betahistine Used For?
Betahistine is prescribed for:
to reduce the frequency and severity of vertigo attacks, and to alleviate associated tinnitus, hearing fluctuation, and aural fullness.
used off-label or in an unlicensed context for the management of vertigo and dizziness associated with other vestibular conditions, including vestibular neuritis and benign paroxysmal positional vertigo (BPPV), though evidence for these indications is less robust.
Betahistine is not suitable for the immediate relief of an acute vertigo attack. For acute severe vertigo, vestibular sedatives such as prochlorperazine or cinnarizine are used. Betahistine should be taken regularly, every day, to reduce the frequency of attacks over weeks and months. It is a preventative treatment, not a rescue medication.
How Does Betahistine Work?
Betahistine's mechanism of action in Ménière's disease involves several complementary pathways, though its precise mode of action has not been fully characterised:
H1 Receptor Agonism — Betahistine is a weak agonist at peripheral histamine H1 receptors. Stimulation of H1 receptors on blood vessels of the inner ear causes vasodilation and improved microcirculation in the cochlea and vestibule. This is thought to reduce endolymphatic hydrops — the pathological accumulation of endolymph fluid in the inner ear — by facilitating fluid drainage and improving blood flow to the stria vascularis, which regulates endolymph production and absorption.
H3 Receptor Antagonism — Betahistine is a potent antagonist at presynaptic H3 receptors in the central and peripheral nervous system. H3 receptors normally act as autoreceptors that inhibit histamine synthesis and release. By blocking H3 receptors, betahistine disinhibits histamine release in the vestibular nuclei and cochlea, resulting in increased local histaminergic activity, enhanced vestibular compensation, and reduced neurotransmission in vestibular pathways.
Together, these mechanisms reduce the frequency of the endolymphatic pressure fluctuations that trigger episodic vertigo, tinnitus exacerbation, and hearing fluctuation in Ménière's disease.
Dosages & Administration
The correct dose depends on the type and severity of infection, age, weight, and kidney function. Always follow your clinician's instructions. The table below is for general reference only.
Administration Tips
Always take betahistine with food — taking it with meals significantly reduces the nausea that can occur with betahistine, particularly at initiation or at higher doses.
Take at regular intervals throughout the day — dividing the dose maintains more consistent plasma levels and is more effective than single daily dosing.
Allow several weeks to months before judging the effectiveness of betahistine. Unlike acute vestibular sedatives, betahistine's benefit accumulates over time. Do not discontinue prematurely.
Do not stop betahistine abruptly — while no significant discontinuation syndrome exists, stopping suddenly may allow vertigo attack frequency to return to baseline. Any dose reduction should be gradual and clinically guided.
Take every day, even on days when symptoms are absent — consistent daily use is essential for preventative benefit.
Side Effects of Betahistine
Betahistine is generally very well tolerated. Most side effects are mild and gastrointestinal in nature, and are substantially reduced by taking the medication with food.
- Nausea (most common, particularly at initiation; taking with food significantly reduces this)
- Headache
- Gastrointestinal discomfort (bloating, indigestion, abdominal pain)
- Mild pruritus (skin itching)
- Rash
- Severe allergic reaction (anaphylaxis) — rare; facial swelling, difficulty breathing, urticaria, collapse
- Severe skin reactions — rare; angioedema
- Gastrointestinal ulceration — rare; betahistine should be used with caution in patients with a history of peptic ulcer disease
Betahistine should be used with caution in patients with asthma, as its histaminergic activity may theoretically provoke bronchospasm in susceptible individuals. It should also be used with care in patients with active or recent peptic ulcer disease. Inform your clinician of these conditions before starting treatment.
Drug Interactions
Betahistine has a relatively limited interaction profile. Always disclose all medications and supplements to your clinician or pharmacist.
MAOIs inhibit the metabolism of betahistine (via monoamine oxidase), significantly increasing betahistine plasma levels and the risk of adverse effects. Concurrent use should be avoided.
Classical antihistamines block H1 receptors and may theoretically reduce the peripheral vasodilatory effects of betahistine. Clinical significance is uncertain, but concurrent use may diminish betahistine's efficacy. Discuss with your clinician if you take regular antihistamines.
Betahistine may potentially enhance the effects of beta-2 agonists via histaminergic pathways; clinical significance is minimal.
Important Warnings
Betahistine is contraindicated in patients with phaeochromocytoma — a rare tumour of the adrenal gland. Its histaminergic properties could theoretically stimulate catecholamine release from the tumour, precipitating a hypertensive crisis. Inform your clinician if you have been diagnosed with a phaeochromocytoma.
Betahistine should be used with caution in patients with asthma. Its weak H1 agonist activity may theoretically exacerbate airway hyperresponsiveness. Patients with asthma should be monitored for any worsening of respiratory symptoms during treatment.
Betahistine may stimulate gastric acid secretion via histaminergic pathways. Use with caution in patients with active peptic ulcer disease or a history of significant gastrointestinal bleeding.
There are insufficient data to confirm the safety of betahistine during pregnancy. It should be avoided unless the benefit clearly outweighs the risk. It is not recommended during breastfeeding, as its excretion into breast milk and effects on the nursing infant are unknown.
Speak to a Clinician About Treatment
Getting advice no longer means sitting in a waiting room. Through The GP Service, you can consult with a licensed clinician in minutes — from home, on your lunch break, or wherever works for you. If treatment is clinically appropriate, your clinician can issue a prescription during the consultation. A consultation does not guarantee a prescription.
The treatment you need, when you need it.
Betahistine FAQs
Betahistine is a long-term preventative treatment, not an acute remedy. Most patients begin to notice a reduction in vertigo attack frequency after 4 to 8 weeks of consistent treatment, though full benefit may take 3 to 6 months to establish. It is important to persist with treatment even if initial results are not immediately apparent.
No. Betahistine is not effective for aborting an ongoing vertigo attack. If you are experiencing an acute attack of vertigo, a vestibular sedative such as prochlorperazine (Buccastem) or cinnarizine is more appropriate for symptom relief. Betahistine should continue to be taken daily to prevent future attacks.
Clinical evidence suggests that higher doses — typically 48 mg/day (16 mg three times daily) or even higher under specialist supervision — are generally more effective than lower doses in Ménière's disease. If symptoms are not well controlled on standard doses, discuss with your clinician whether a dose increase is appropriate.
Betahistine primarily targets vertigo frequency in Ménière's disease. Some patients report improvements in tinnitus and aural fullness as overall Ménière's control improves, but betahistine is not a specific tinnitus treatment and results for this symptom are variable.
No. Despite the name, betahistine is not a classical antihistamine — it actually acts in a largely opposite way, functioning as a histamine analogue (a partial H1 agonist and potent H3 antagonist). Classical antihistamines such as cetirizine and loratadine block H1 receptors and would theoretically reduce betahistine's peripheral effects. Do not take betahistine and a classical antihistamine simultaneously without discussing this with your clinician.